This study provides the first in vivo evidence that nanochelate-based BCc1 modulates autophagy-associated genes (Beclin-1, ATG-4B, ATG-7) and the mTOR signaling pathway in a BALB/c BC model. The gene discussed is MTOR; the disease is breast cancer.